Similar articles

• [Classification of chronic hepatitis (staging) and serum HCV-RNA levels].

  Inoue O, Yatsuhashi H, Koga M, Yano M. Inoue O, et al. Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):600-1. Nihon Rinsho. 1995. PMID: 7563839 Japanese. No abstract available.
• Predictive factors for efficacy of interferon therapy in chronic hepatitis type C.

  Ishibashi K, Kashiwagi T, Ito A, Tanaka Y, Nagata T, Tamaki J, Azuma M, Kishida Y, Yoshida A, Hikiji AY. Ishibashi K, et al. Hepatogastroenterology. 1995 Sep-Oct;42(5):535-41. Hepatogastroenterology. 1995. PMID: 8751211
• Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.

  Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V, et al. Martinot-Peignoux M, et al. Hepatology. 1995 Oct;22(4 Pt 1):1050-6. Hepatology. 1995. PMID: 7557850 Clinical Trial.
• [Histological activity index score and levels of hepatitis C virus RNA in chronic hepatitis C].

  Takahashi M, Yamada G. Takahashi M, et al. Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):602-7. Nihon Rinsho. 1995. PMID: 7563840 Review. Japanese. No abstract available.
• [Serum levels of HCV-RNA determined by branched DNA (bDNA) probe assay in chronic hepatitis C].

  Osada T, Iwabuchi S, Iino S. Osada T, et al. Nihon Rinsho. 1995 Sep;53 Suppl(Pt 1):287-93. Nihon Rinsho. 1995. PMID: 7563727 Review. Japanese. No abstract available.